TET2 and atherosclerosis: Concurrently, the discovery of the role of miR-33a/b in dyslipidemia (2011) [6] and the identification of TET2 deficiency in accelerating atherosclerosis (2017) [23] have highlighted the coordinated involvement of multiple epigenetic mechanisms in cardiovascular disease.